News

Bailong Chuangyuan: China's Allulose Leader Poised for Global Growth   Domestic Capacity Leader Bailong Chuangyuan currently operates 15,000 tons of crystalline allulose capacity , the largest in China and second globally. The company was the "first in China" to achieve industrial-scale allulose production and revenue. Its "15,000 tons crystalline sugar project" (including 5,000 tons allulose) is ramping up utilization, with further sales growth expected in 2026. Global Expansion Underway The Thailand Smart Health Factory,  a ¥748 million investment – is under construction and will add "12,000 tons of crystalline allulose and 7,000 tons of liquid allulose" upon completion. This will "double" the company's allulose capacity and establish an overseas production base to reduce tariffs and mitigate trade risks. Technology & Market Position With 14 allulose-related patents (including 6 PCT patents) covering strain cultivation and production processes, Bailong achieves over 99.5% crystalline purity. The company holds the 2 global market share in allulose (2024), with overseas revenue accounting for "67%" of total sales. 2026 Outlook With China's allulose approval in July 2025 and the mandatory sugar labeling standard taking effect in March 2027, domestic demand is poised to accelerate. As the domestic capacity leader with a clear global expansion roadmap, Bailong is well-positioned to capture this growth wave.

The global sweetener market reached $17.84 billion in 2025, up 8.2% from 2024, and is projected to exceed $26.5 billion by 2030, with a compound annual growth rate (CAGR) of approximately 6.8% during the period. The Chinese market accounted for about 32% of global consumption, with its market size reaching RMB 38.46 billion in 2025, a year-on-year increase of 9.5% — outpacing the global average. The core drivers of this growth stem from the sustained release of sugar-reduction demand fueled by rising health awareness, alongside intensive efforts by food and beverage companies to roll out low-calorie and zero-calorie products. In terms of product mix, natural sweeteners (e.g.: Resistant Dextrin, Polydextrose, FOS, IMO, GOS, Crystalline Fructose and etc.) increased their share from 22% in 2020 to 37% in 2025, with steviol glycosides and mogrosides posting CAGR of 14.2% and 18.7%, respectively. Meanwhile, artificial sweeteners such as aspartame and acesulfame K saw their shares contract by 3–5 percentage points, reflecting how consumer preference for "clean-label" products is reshaping the supply landscape. Consumer behavior surveys show that in 2025, 73.6% of respondents proactively checked the types of sweeteners listed on ingredient labels when purchasing packaged foods, up 21 percentage points from 2022. Distribution channels have shown divergent trends: sales growth of sweetener-containing end-products in traditional supermarkets was only 4.1%, while emerging channels such as community group-buying and livestream e-commerce grew at a robust 26.8%, accounting for over 19% of total retail sales. In the foodservice sector, ready-to-drink tea and coffee chain brands increased their procurement of natural sweeteners by 31.2% year-on-year in 2025, driving the B2B supply system toward customization, small-batch production, and higher purity levels. At the same time, cost pressures are taking effect — raw material prices for natural sweeteners rose 12–15% year-on-year in 2025 due to climate conditions and planting area fluctuations, forcing companies to reduce production costs through technological pathways such as enzymatic conversion and fermentation-based alternatives. On the policy front, China, the European Union, and several Southeast Asian countries intensively updated their food additive usage standards during 2024–2025. In March 2025, China's National Health Commission issued a new version of national food safety standards, which refined the maximum usage levels of novel sweeteners such as erythritol and allulose in beverages and dairy products, while also mandating separate labeling of "added sugars" and "sweeteners" on product packaging. The EU, starting in 2025, tightened the acceptable daily intake (ADI) for certain artificial sweeteners by 15–25%, directly affecting the export strategies of related manufacturers targeting the European market. In Southeast Asia, the implementation of sugar taxes in Thailand, Indonesia, and the Philippines spurred localized production capacity for low-sugar and sugar-substitute products in the region. In the patent and technology domain, a clear trend toward "naturalization" and "biosynthesis" has emerged. As of the first quarter of 2026, among active global sweetener-related patents, 41% involve recrystallization and purification of steviol glycosides, enzymatic synthesis of rare sugars, and microbial fermentation for mogroside production. Chinese applicants accounted for 56% of the total global patent count in these fields. Among patents published in 2025, 34 were directly related to improvements in the industrial-scale production process of allulose, with single-batch conversion rates increasing from 65% to 82%. These technological breakthroughs are propelling domestic Chinese sweetener companies to shift from "raw material contract manufacturing" to "technology-plus-brand" players in the global supply chain. At the business and innovation level, leading companies are transitioning from single-ingredient suppliers to "solution providers." In 2025, the industry saw seven joint R&D agreements involving "sweetener plus functional ingredients," covering compound formulations with dietary fiber, vitamins, prebiotics, and more. OEM/ODM service revenue accounted for over 30% of total revenue among leading sweetener companies for the first time. Some companies launched "7-day custom formulation" services for small and medium-sized brand clients, significantly shortening new product launch cycles. Additionally, pilot applications of blockchain traceability in sweetener raw-material supply chains covered approximately 120,000 mu (about 8,000 hectares) of planting bases in China's Yunnan and Guangxi regions in 2025, enhancing traceability for export products. In terms of trade and import/export, China's total sweetener exports reached 673,000 metric tons in 2025, up 11.2% year-on-year. High-intensity sweeteners (neotame, sucralose) accounted for 36% of export value, though their unit export price fell 3.8% year-on-year, reflecting intensified global market competition. On the import side, the trend was characterized by "high-end raw material sourcing": imports of natural sweetener intermediates from Southeast Asia by domestic enterprises grew 42.1% in value in 2025, primarily for further value-added processing. The impact of U.S.-China trade friction on sweetener tariffs eased in 2025, with tariffs on certain categories exported to the U.S. reduced to 5.2%, driving export volumes to the U.S. back up to 197,000 metric tons. Although the EU's Carbon Border Adjustment Mechanism (CBAM) pilot phase did not directly include sweeteners, major producers have already begun preparing carbon footprint accounting systems. On the strategic development front, the industry is focusing on three main tracks: upstream — globalized planting and risk hedging of raw materials; midstream — cost reduction and efficiency improvement (particularly the large-scale application of continuous chromatographic separation and membrane filtration technologies); and downstream — vertical deep-diving into application scenarios (pharmaceuticals, daily chemicals, pet food, and other non-traditional sectors). During 2025–2026, multiple companies have launched pilot-scale production lines based on synthetic biology approaches, aiming to achieve cell-factory mass production of certain rare sweeteners by 2028, which could fundamentally reshape the industry's cost curve. In terms of regional competition, Chinese companies, leveraging scale advantages and rapid iteration capabilities, increased their global market share in natural sweeteners from 29% in 2020 to 44% in 2025. However, with emerging producing regions in India and South America on the rise, maintaining technological moats remains a critical challenge.

Bailong Chuangyuan Makes a Strong Debut at FiA Shanghai 2026, Showcasing Comprehensive Functional Food Ingredient Solutions for Global Health Food Innovation   On June 15, the 27th Hi&Fi Asia-China – the premier exhibition for health ingredients and natural food additives – grandly opened at the National Exhibition and Convention Center in Shanghai. As a benchmark event in Asia's food ingredients sector, this year's exhibition placed a strong emphasis on emerging industry pillars such as sugar reduction and low-fat formulation, gut-nourishing functional food components, and naturally sourced bioactive ingredients, bringing together thousands of high-quality supply chain enterprises from around the globe.   Bailong Chuangyuan made a prominent appearance at Booth 41B40, Hall 4.1, presenting its full portfolio of functional food ingredients and integrated one-stop food formulation solutions. The company engaged with international buyers and industry partners to jointly explore the vast opportunities within the health and wellness ingredient market. As a nationally recognized "Specialized and Sophisticated SME Champion" in China's functional sugar industry, Bailong Chuangyuan has cultivated extensive expertise in prebiotic food components, health-promoting dietary fibers, and natural low-calorie sweeteners. Backed by an integrated full-chain production system, the company exports its products to over 60 countries and regions, providing in-depth services to food manufacturers across dairy, beverages, bakery, infant formula, and dietary supplements. Aligning with prevailing health-conscious consumption trends, the company spotlighted three flagship product categories at the show:   ✨ Allulose – A Benchmark in Domestic Large-Scale Production: As a zero-calorie natural sweetener with a taste profile remarkably close to sucrose, Bailong's allulose is ideally suited for bakery, beverages, and meal replacement applications, effectively resolving the industry-wide challenge of maintaining palatability while reducing sugar content.   ✨ Premium Dietary Fiber Series – Resistant Dextrin and Polydextrose: These high-performance health-promoting dietary fibers are engineered to accommodate both hot- and cold-process manufacturing, offering excellent solubility and broad formulation flexibility. They empower food brands to effortlessly develop high-fiber health-oriented products, enabling meaningful product differentiation and nutritional upgrading.   ✨ Comprehensive Prebiotic Portfolio – FOS, GOS, and IMO: Covering a full range of specifications, the company's prebiotic food components – including fructo-oligosaccharides, galacto-oligosaccharides, and isomaltooligosaccharides – are precisely tailored to support gut health across all life stages, from infants to adults and seniors. With full regulatory compliance, these ingredients are ideally positioned for premium infant nutrition and functional food product development. The exhibition booth drew sustained high traffic, with sourcing professionals, R&D specialists, and strategic partners engaging in productive discussions. The company's integrated team – spanning R&D, sales, and quality control – provided on-site technical consultations, offering one-on-one in-depth support covering ingredient selection, customized formulation design, production capacity alignment, and regulatory compliance. Over the course of the event, multiple sample trials and cooperation agreements were initiated, effectively streamlining upstream and downstream commercial connections.   Leveraging this premier industry platform, Bailong Chuangyuan gained precise insights into emerging global trends in food ingredients, actively networked with key industry stakeholders, and deepened its strategic footprint in both domestic and international markets. Looking ahead, the company remains steadfast in its commitment to advancing R&D in functional and health-oriented raw materials, continuously upgrading its product systems, refining custom service capabilities, and reinforcing its production capacity advantages. By delivering high-quality, clean-label formulation solutions sourced from China, Bailong Chuangyuan is dedicated to driving global food brand innovation and partnering with industry peers to achieve shared success in the rapidly evolving health-conscious consumer landscape.

Spanning China and Korea, Bailong Chuangyuan is simultaneously exhibiting at the 27th Hi&Fi Asia-China and Seoul Food & Hotel 2026 — showcasing its full portfolio of functional ingredients to domestic and international partners at both shows. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. has spent years developing and manufacturing natural health ingredients across three core categories: functional prebiotics, dietary fiber, and healthy sugars & sugar alcohols. Key products include Resistant Dextrin, Allulose, Fructooligosaccharides (FOS), and Isomaltooligosaccharides (IMO). Backed by an integrated full-chain production system, rigorous quality control, and cutting-edge R&D capabilities, our products are widely applied across dairy, nutraceuticals, functional beverages, and more. At both exhibitions, we will be presenting a range of premium, natural, and clean-label ingredient solutions — spotlighting the latest trends in the global health industry and offering one-stop access to our core R&D achievements and customized formulation services. 27th Hi&Fi Asia-China Health Ingredients Exhibition  Date: June 15–17, 2026 Venue: National Exhibition and Convention Center, Shanghai  Booth: 41B40 Seoul Food & Hotel 2026  Date: June 9–12, 2026  Venue: KINTEX, Goyang, South Korea  Booth: 5C103-104 Our team of technical and sales specialists will be on-site for one-on-one consultations covering ingredient selection, formulation optimization, and custom project development. From R&D to market application, we provide full-chain resource matching to help partners uncover new opportunities in the global health industry. We look forward to seeing you at Booth 41B40 in Shanghai — let's meet face to face and explore what we can build together.

Sugar brings pleasure and serves as an important source of energy for the human body. As living standards rise, the intake of added sugars — both directly and indirectly — has been steadily increasing. However, changes in lifestyle and work patterns have led to a decline in physical labor and overall activity levels, making it difficult for the body to consume the sugar it takes in in a timely manner. Excess sugar that isn't used promptly not only contributes to obesity but may also increase the risk of type 2 diabetes and cardiovascular diseases. Additionally, sugar can promote the fermentation of bacteria in the mouth, leading to tooth decay. As health awareness among the public grows, sweeteners(such as resistant dextrin, polydextrose, FOS, GOS and etc.) that reduce sugar without sacrificing sweetness — often called "sugar substitutes" — are being used in an increasing number of applications. These can be found everywhere from sweets like beverages, candies, and pastries to non-sweet products such as sauces and condiments. Sweeteners have become an indispensable ingredient, especially in the low-sugar and sugar-free food market. Driven by strong downstream demand, the production of sweeteners is rising. In 2025, China's sweetener output reached approximately 331,000 metric tons, and it is expected to reach 353,000 metric tons in 2026. With continuous technological advancements and evolving consumer preferences, the sweetener market is also seeing ongoing innovation and development. The extraction and purification technologies for natural sweeteners are improving, further expanding the range of applications for these natural alternatives.  

Bailong Chuangyuan is a leading manufacturer specializing in the research, development, and production of high-quality dietary fiber, prebiotics, and sugar substitutes. Committed to innovation and excellence, the company serves global customers in the food, beverage, health supplement, and pharmaceutical industries. With a strong focus on quality control and sustainable development, BAILONG CHUANYUAN continues to drive progress in the health ingredients sector, delivering science-based solutions that promote wellness worldwide. News ContentIn celebration of the upcoming International Workers’ Day, BAILONG CHUANYUAN successfully wrapped up its 2026 “Labor Day” Sports Meet on April 25, 2026. The event was held to enrich the cultural and sports life of employees, strengthen team cohesion, and showcase the energetic and enterprising spirit of the BAILONG CHUANYUAN team. Through sports, colleagues relieved stress, built friendships, and honored the spirit of labor with vitality and enthusiasm. The sports meet focused on three main events: basketball, badminton, and table tennis. Employees competed with passion and sportsmanship, turning each match into a celebration of teamwork and determination. On the basketball court, players in uniform jerseys demonstrated seamless coordination, sharp breakthroughs, and accurate shooting. With every whistle, offense and defense shifted rapidly—dribbling, shooting, blocking, and fast-breaking—creating thrilling moments that drew continuous cheers from the sidelines. The badminton matches were a dynamic display of speed and skill. Players moved swiftly on the court, engaging in intense rallies where every point was hard-earned, fully reflecting the competitive spirit of the sport. Table tennis matches were equally exciting, with the ball flying back and forth across the table. Each precise return was met with enthusiastic applause from the audience. Whether it was the teamwork on the basketball court, the relentless pursuit of excellence in badminton, or the agile competition in table tennis, all the events embodied the sportsmanship of “never giving up” and highlighted the united and striving spirit of BAILONG CHUANYUAN employees. The conclusion of the sports meet marks a new beginning. The fighting spirit and collaboration demonstrated during the event will be carried forward into daily work. BAILONG CHUANYUAN will continue to organize a variety of cultural and sports activities to enhance team cohesion, support employees in their growth through dedication, and work together toward a new chapter of high-quality development.  

On May 15, 2026, the 4th Member Congress and the 1st Session of the 4th Board of Directors (Enlarged) of the China Biofermentation Industry Association was held in Tianjin. The congress focused on new opportunities and directions for industry development, and presented awards to benchmark enterprises that have made outstanding contributions in areas including industrial upgrading, technological innovation, and green development. At the event, Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. was officially presented with the "China Biofermentation Industry Association — Advanced Enterprise in the Biofermentation Industry · Industry Contribution Award", in recognition of its long-term commitment to the biofermentation sector, sustained technological breakthroughs, and solid contributions to the industry. As a Vice-Chairman unit of the China Biofermentation Industry Association, Bailong Chuangyuan has remained deeply rooted in functional biofermentation as its core business. Driven by technological innovation, the company has achieved continuous breakthroughs in the R&D, production, and industrial application of key products including Resistant Dextrin, Allulose, and Fructooligosaccharides (FOS) — building a full-chain innovation system spanning strain development, process optimization, and end-use application.   This award represents authoritative recognition from the industry association and the market for Bailong Chuangyuan's years of dedicated effort, and reflects the industry's confidence in the company's future development. Going forward, Bailong Chuangyuan will continue to uphold its innovation-driven spirit, deepen its focus on biofermentation, and deliver superior products and services to customers — working hand in hand with industry partners to drive China's biofermentation industry toward a new stage of high-quality development.

Ordinary Hero, Guardian of Hope – Bailong Chuangyuan Employee’s Courageous Act Saves a Life In moments of crisis, true character shines. Recently, one of our employees encountered a person showing signs of attempting self-harm. Without a moment’s hesitation, she stepped forward in this critical moment, demonstrating remarkable courage and heartfelt compassion, and successfully saved a young life at the brink. Her actions are a powerful testament to the spirit of helping others in emergency and the light of human kindness. This warm-hearted act did more than save a precious young life—it also preserved the happiness and wholeness of a family. Risking her own safety without a second thought, our employee reached out proactively to help a stranger in despair. Through this simple yet profound act of goodwill, she embodied the values of moral integrity, kindness, and social responsibility that our company holds dear. We extend our highest praise and sincere respect to this employee for her heroic and selfless actions. We also call upon all our team members to follow her example—to actively promote a spirit of justice and compassion, to stay true to our core values while fulfilling everyday duties, and to spread warmth through caring hearts. Let us take the initiative to embrace our social responsibilities, support those in need, and through small acts of kindness, build a powerful force of empathy and goodwill that reflects the very best of our corporate family.  Prebiotics, dietary fiber.

Recently, Bailong Chuangyuan successfully obtained the production license for D-allulose, marking that the company’s allulose products are now officially qualified for compliant mass production and full-scale market launch. This achievement represents another key step in the company’s strategic layout in the functional sweetener sector.   As a leading enterprise in the domestic sugar substitute industry, Bailong Chuangyuan boasts strong product strength in the allulose field. Over the years, the company has continuously deepened its core technology research and development for allulose, accumulating mature production processes and a comprehensive quality control system. Supported by complete production facilities, a professional R&D team, and stringent production standards, the company has laid a solid foundation for stable product output and quality assurance. Since 2014, Bailong Chuangyuan has focused its R&D efforts on next-generation products such as crystalline allulose. In 2016, it achieved industrial-scale production of liquid allulose, and in 2019, it overcame crystalline technology challenges to realize mass production. The company is also a participating unit in the pre-classification of allulose under the customs import and export tariff code. Currently, Bailong Chuangyuan has obtained 14 allulose-related patents, including 8 domestic patents and 6 international PCT patents, covering areas such as strains, production processes, and product characteristics.   On July 2, 2025, the National Health Commission (NHC) announced in its 2025 Bulletin No. 4 that allulose has been included as a new food ingredient, covering both fermentation-based and enzymatic production processes. Bailong Chuangyuan’s allulose products fully comply with the requirements set forth in the NHC announcement. With regulatory approval in China, allulose holds vast market potential. It can be widely used in beverages, bakery products, dairy, and other sectors, driving innovation and upgrading of sugar-free products. Bailong Chuangyuan’s allulose offers multiple advantages: in terms of taste, its sweetness is close to that of sucrose, delivering a pleasant sensory experience to consumers, while its calorie content is extremely low—approximately one-tenth that of sucrose—meeting the growing consumer demand for healthy, low-sugar products. In terms of stability, the product exhibits excellent thermal and acid stability, making it suitable for various demanding conditions in food processing and enabling broad applications in beverages, bakery, dairy, and more. Additionally, the product features high purity, backed by rigorous quality testing to ensure every batch meets high-standard quality requirements. Following the approval of this license, the company will further leverage its allulose production capacity advantages, accelerate market expansion both domestically and internationally, and enrich its product portfolio. Looking ahead, Bailong Chuangyuan will continue to focus on the health industry, drive technological innovation and product upgrades, empower the transformation and upgrading of the food industry with high-quality ingredients, and support the company’s steady, high-quality development.  

    Focusing on new trends in healthy baking, exploring new opportunities for industry development! From May 20 to 23, the 28th China International Bakery Exhibition (Bakery China 2026) will grandly open at the National Exhibition and Convention Center (NECC) in Hongqiao, Shanghai. Bailong Chuangyuan will present its healthy baking ingredient solutions at this major exhibition, and sincerely invites global customers and industry partners — both old and new — to visit our booth 82K06 for dialogue, collaboration, and innovation!   · Booth Information: 82K06 · Exhibition Dates: May 20–23, 2026   · Venue: National Exhibition and Convention Center (NECC), Hongqiao, Shanghai (No. 333 Songze Avenue)   · Bailong Chuangyuan Booth: 82K06       Shandong Bailong Chuangyuan Bio-tech Co., Ltd. (abbreviated as Bailong Chuangyuan, stock code: 605016) is a national high-tech enterprise integrating production, academia, and research, with bioengineering as its core industry. Bailong Chuangyuan is dedicated to the development of functional sugars and the bio-fermentation industry, focusing primarily on the production of functional food ingredients. The company leverages its industrial strengths and is committed to advancing nutritional health. Its core products include resistant dextrin, fructo-oligosaccharides (FOS), D-allulose, isomalto-oligosaccharides (IMO), polydextrose, galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), liquid maltitol, crystalline maltitol, and more.  

On May 10th — China's 10th "China Brand Day" — the 2026 China Brand Value Evaluation release event was held in Deqing, Zhejiang. The event was co-organized by the China Council for Brand Development and the Xinhua News Agency Brand Affairs Office, and hosted by China Brand magazine. It stands as one of the most authoritative and professionally rigorous public brand recognition events in China.     Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (Stock Code: 605016) was once again selected for the ranking, with its brand value continuing to rise — driven by deep brand heritage, strong technical capabilities, and outstanding industry influence. This recognition further cements Bailong Chuangyuan's position as a benchmark enterprise in China's functional sugar industry.   As a leading company in the field of healthy functional ingredients, Bailong Chuangyuan has dedicated over 20 years to the industry, consistently guided by the principles of technology-driven innovation, uncompromising quality, and brand-centered development. Recognized as a National High-Tech Enterprise and a "Little Giant" Specialized & Innovative enterprise, the company has built deep expertise across three core product categories: prebiotics, dietary fiber, and healthy sweeteners.   With independent innovation as its driving force, Bailong Chuangyuan has established strong technological barriers and a comprehensive R&D system. The company holds over 90 authorized patents (including international patents) and has led or participated in the development of multiple national and industry standards, continuously driving technological advancement across the sector. Backed by this innovation strength, Bailong Chuangyuan's products are supplied long-term to leading customers both domestically and internationally, with its global market share steadily growing.   Being included in the 2026 China Brand Value Evaluation represents dual recognition from authoritative institutions and the market alike — and with this honor comes greater responsibility. Looking ahead, Bailong Chuangyuan will seize this milestone as new momentum: staying true to its founding mission, deepening its core business, and pursuing continuous innovation. The company is committed to enhancing its brand competitiveness, delivering superior products, cutting-edge technology, and a stronger global brand presence — empowering the global health industry and contributing the "Bailong strength" to the high-quality development of Chinese brands worldwide.

Shanghai, May 6–7, 2026 – Bailong Chuangyuan (SSE: 605016), a leading supplier of functional oligosaccharides and dietary fibers, will exhibit at the first Human & Pet Nutrition Technology Linkage Conference in Shanghai. Booth 10 | Shanghai Dahuahua Qiaojia Holiday Inn ? What Bailong Chuangyuan Brings to the Table Bailong Chuangyuan will present its human-pet dual-use functional ingredient for intestine health, which includes: 1. FOS (Fructo-oligosaccharide) 2. GOS (Galacto-oligosaccharide) 3. XOS (Xylo-oligosaccharide) 4. IMO (Isomalto-oligosaccharide)     These ingredients are our prebiotic products, widely recognized for their high thermal and processing stability, proven safety profile, and functional efficacy – making them particularly suitable for modern pet food applications such as kibble coatings, wet food blends, and nutritional supplements. ? Who Should Connect Bailong Chuangyuan is looking to engage with:   Feed producers seeking functional dietary fiber solutions Farming groups interested in gut health optimization for livestock and companion animals Pet food companies looking for ingredient supply and collaborative formulation development Bailong Chuangyuan – Bringing Human Nutrition Excellence to Pet Health. See you in Shanghai!

    As global consumers become increasingly health-conscious, the push to reduce sugar intake has turned into a major dietary trend. Excessive sugar consumption is not only linked to blood sugar and lipid imbalances but is also closely associated with chronic diseases such as obesity and diabetes. In response, many countries have introduced policies to curb sugar use, with some levying sugar taxes to drive down consumption of sugary drinks. Against this backdrop, sugar substitutes have emerged and rapidly gained traction. Natural sweeteners, in particular, are gradually replacing certain artificial alternatives and becoming the focal point of the market.     According to industry data, the global sugar substitute market reached $22.1 billion in 2024, marking an 8.1% year-on-year increase. China’s market, meanwhile, stood at RMB 10.1 billion, with a growth rate of 20.9% — far exceeding the global average. In terms of penetration, sugar substitutes accounted for only about 10% of the global sweetener ingredient market in 2019, indicating substantial room for expansion. The current ratio between natural and artificial sweeteners is roughly 4:6, but as health awareness deepens and new natural sweeteners are developed, the penetration of natural options is steadily rising.     Among the many natural sweeteners, allulose stands out as one of the most promising newcomers, thanks to its taste profile, which closely resembles that of sucrose, and its excellent functional properties. Allulose is about 70% as sweet as sucrose but contains only 0.3% of the calories. It does not participate in human glucose metabolism and causes no significant fluctuations in blood sugar or insulin levels. Studies have also shown that allulose offers a range of physiological benefits, including neuroprotection, blood sugar regulation, and lipid reduction, while being better tolerated by the digestive system compared to sugar alcohols.     Notably, allulose is the only sugar substitute capable of undergoing the Maillard reaction — the chemical process responsible for the golden-brown color and appealing aroma of baked goods like breads and pastries. Traditional sweeteners cannot replicate this effect. As a result, allulose is expected to help expand the application of sugar substitutes from beverages into a wider array of food categories, including baked goods, confectionery, and condiments.     To date, allulose has been approved as a food ingredient in several countries, including the United States, Japan, South Korea, Mexico, and Singapore. The global allulose market was valued at approximately 200 million in 2024 and is projected to reach 200millionin2024andisprojectedtoreach200million in 2024 and is projected to reac500 million by 2030. In China, the approval process has been advancing steadily. In 2021, the National Health Commission (NHC) accepted the application to classify allulose as a new food ingredient. In 2024, D-allulose-3-epimerase was approved as a food processing enzyme. Finally, on July 2, 2025, the NHC and the State Administration for Market Regulation officially approved allulose as a new food ingredient — a milestone that opens the door for its application in the domestic market.     In terms of downstream applications, sugar-free beverages remain the dominant segment for sugar substitutes. China’s sugar-free beverage market reached RMB 57.05 billion in 2024, with a compound annual growth rate (CAGR) of 42% between 2019 and 2024. However, the penetration rate for sugar-free beverages in China is only about 10%, far lower than in developed countries such as Japan. Sugar-free tea and carbonated sugar-free drinks are the two main categories, with sugar-free sparkling water gaining rapid popularity thanks to the “zero sugar, zero calories” concept, driving demand for sweeteners like erythritol. With the growing adoption of allulose, both the taste and health profile of beverages are expected to improve further.     Looking at consumer demographics, young women are the primary buyers of sugar-free beverages. Their top concerns are product taste, health and fat-reduction benefits, and ingredient composition. This suggests that consumers are less price-sensitive and more focused on balancing health with flavor — a favorable environment for novel sweeteners like allulose, which satisfy taste needs while offering functional health benefits.     From an industry chain perspective, only a handful of companies worldwide have achieved large-scale allulose production. Among domestic players, Bailong Chuangyuan was the first in China to commercialize allulose, with current crystal allulose capacity of 15,000 tons, and is building an additional nearly 20,000 tons of capacity at its factory in Thailand. Their products include resistant dextrin, polydextrose, oligosaccharides and so on.      In international markets, the application of allulose is growing rapidly. Between 2017 and 2021, the number of new products containing allulose in the Asia-Pacific region surged by 1,300%. Major brands such as Coca-Cola, Suntory, and Uni-President have launched allulose-containing beverages. Allulose is also showing broad potential in confectionery, condiments, sports nutrition, weight management, and even diabetes-specific foods. For example, Halo Top in the U.S. offers a low-sugar ice cream combining allulose and inulin, which preserves taste while reducing fat absorption. Japan has included allulose in its list of foods for diabetic patients, with studies showing it can suppress post-meal blood sugar spikes by up to 25%. Source from: Sohu

YUCHENG, Shandong — Against the backdrop of Healthy China initiatives and global food-industry transformation, Bailong Chuangyuan Biotechnology Co., Ltd., founded in 2005 in Yucheng, has emerged as a driving force in the health-sugar, dietary-fiber and prebiotic sectors. Since listing in 2021, the national high-tech enterprise has expanded R&D, production and sales capabilities and is among a handful of global suppliers with multi-product, large-scale production of health-food raw materials.   Adhering to an industrial-first ethos amid a complex market environment, the company has pursued high-quality development through project construction, technological innovation, global expansion, refined management, Party-led governance and social responsibility. In 2025 the firm delivered a step-change in performance, posting total operating revenue of RMB 1.379 billion, up 19.75% year-on-year, and net profit of RMB 369 million, up 50.06%, achieving both economic and social gains. Reporter: Li Hongzhen   Project Foundation: Upgrading the Industry Chain Focusing on core business and capacity strengthening, Bailong Chuangyuan has optimized output and extended its industrial chain through key projects. The company pushed intelligent capacity upgrades, expanded high-end product lines and extended upstream and downstream linkages to raise both capacity and quality, and to improve efficiency and returns.   On the production side, automation, digitalization and consolidation initiatives upgraded equipment and processes to boost yield and energy utilization while reducing costs and emissions. In 2024 two major projects reached production — an annual 30,000-ton soluble dietary fiber line and a 15,000-ton crystalline sugar line. Both projects integrated digital-twin technology, DCS and real-time monitoring to enable unmanned workshop operations, cutting comprehensive energy consumption by over 40% and markedly improving efficiency and product quality.   Strategic vertical extension and horizontal collaboration guide the company’s supply-chain layout. Strategic partnerships with premium raw-material bases ensure supply and quality control, while customized solutions for downstream sectors — food & beverage, health products and feed — have transformed the company from a single-product supplier into a full-solution provider. Dedicated teams serving leading clients such as Mengniu and BY-HEALTH deepen cooperation and raise product value. These efforts have yielded a resilient, competitive full-chain structure and multiple national and provincial honors, including “Specialized and New” Little Giant, National Green Factory and top rankings in light industry and private-enterprise innovation.   Innovation-Driven: Securing the Technological High Ground Innovation sits at the core of Bailong Chuangyuan’s strategy. Combining in-house R&D with industry–university–research collaboration, the company operates high-standard R&D and testing centers and a professional research team focused on strain breeding, bioprocessing and enzyme engineering. A full-cycle innovation and commercialization mechanism has led to breakthroughs in key technologies.   To date the company has filed over 150 patents and been granted more than 90, including about 80 domestic invention patents and 11 overseas invention patents. It has undertaken national and provincial research projects, received multiple provincial-level science and technology awards, and collaborates with institutions such as Shandong University, Jiangnan University and the China Food Fermentation Research Institute to promote industrialization of advanced technologies.   In November 2025, a joint project with Jiangnan University on “Bio-manufacturing Key Technologies and Industrialization for Functional Carbohydrates” was recognized among 14th Five-Year Plan advanced science-and-technology achievements in light industry, addressing industry bottlenecks and supporting efficient, green production of health-food raw materials. The company pioneered rare sugar D-allulose R&D in 2014, scaled liquid production in 2016, and achieved crystallization technology and industrial production by 2019. Its crystalline D-allulose now exceeds 99.5% purity and is protected by 14 related patents. The company also contributes to national and industry standards, leveraging innovation to offer tailored low-/no-sugar and high-fiber ingredient solutions for major downstream brands.   Global Expansion: Two-Way Market Strategy Executing a “domestic base, global reach” strategy, Bailong Chuangyuan has synchronized domestic and international market growth. Domestically, a comprehensive sales network and technical services underpin long-term partnerships with leading food and health-product companies; the company has expanded customized D-allulose solutions to meet the rising no-sugar beverage market.   Internationally, the company meets global standards with ISO9001, ISO22000 and BRCGS certifications and exports to more than 60 countries and regions, supplying global brands such as Herbalife and Dumex. In July 2025 it launched a smart health-food raw-materials factory project in Thailand with planned capacities including 12,000 tons of crystalline D-allulose, 7,000 tons of liquid D-allulose, 20,000 tons of resistant dextrin and 6,000 tons of fructooligosaccharides. The Thailand project leverages local raw-material cost advantages to lower production costs and expand access to European, North American, Southeast Asian and Middle Eastern markets, marking a shift from “product export” to “brand and capacity export.”   Overseas operations have become a major growth engine, and the company’s dual domestic-international market model strengthens its position in global value and supply chains.   Management Enablement: A Modern, People-Centered Enterprise Bailong Chuangyuan applies “standardized, refined, and humane” management to optimize governance and processes for stable, efficient operations. Quality control is central: the company enforces full-chain quality management, tight supplier selection and dynamic supplier oversight; real-time monitoring of key production parameters helps maintain an annual product qualification rate above 99.8%.   The company emphasizes people development, improving workplace living conditions and employee benefits, and offering systematic training and promotion channels. In 2025 it delivered 46 training sessions reaching more than 1,200 participants. Regular skills contests, cultural and sports activities, and welfare programs strengthen employee engagement and build a capable team to support growth.   Party Leadership and Social Responsibility Bailong Chuangyuan integrates Party building with business and corporate culture, strengthening Party organizations and promoting model roles for Party members in R&D and production. Party teams contributed to the rapid commercialization of crystallized D-allulose, and frontline Party task forces ensure delivery during peak seasons.   Committed to green development, the company has earned recognition as a National Green Factory and other eco-awards, applying waste-heat recovery and concentrate-recycling technologies to lower carbon emissions. It led the formulation of group standards for D-allulose and continues to advance research into resistant dextrin and other functional sugars to support public health while driving upstream and downstream industry collaboration. Socially, the company engages in long-term philanthropy in education and disability support, and provides employment assistance and technical training for regional development. In 2024 it was named the “Most Socially Responsible Listed Company.”   From a small workshop to a listed company that has broken foreign technology monopolies and built global capacity, Bailong Chuangyuan has expanded scale, efficiency and brand influence through innovation, hard work and responsibility. Looking ahead, the company plans to remain focused on bio-health, strengthen technology and product upgrades, use the Thailand facility to optimize global layout, deepen domestic cultivation and international expansion, advance lean and green operations, and fulfill social responsibilities to contribute to industry development, regional economies and public health.   Captions: 1. New Bailong Chuangyuan production campus 2. Company Party-building activities 3. Aerial view of Bailong Chuangyuan’s Thailand smart-factory project for health-food raw materials 4. Automated production line in the intelligent workshop   Source: Bailong Chuangyuan Biotechnology WeChat official account, 04/21/2026. ----------------------------------------------------------------------------------------------- Shandong Bailong Chuangyuan Bio-tech Co., Ltd., founded on December 30, 2005, covers an area of 140, 000 square meters and operates with a registered capital of 420 million RMB and total assets exceeding 2 billion RMB. With a workforce of over 950 employees, and has an annual comprehensive production capacity of 300, 000 tons. The company has established subsidiaries in Qingdao, Shanghai, Jinan, Nanjing, and Thailand. As a national high-tech enterprise LED by biological engineering, Shandong Bailong Chuangyuan integrates industry, academia, and research. It is a flagship enterprise of the "Functional Sugar City of China" and boasts the widest variety of functional sugars in the country. Bailong Chuangyuan is the first domestic enterprise to produce Resistant Dextrin (Soluble Dietary Fiber). The main products include: Resistant Dextrin, Allulose, Fructo-oligosaccharide, Isomalto-oligosaccharide, Galacto-oligosaccharide, Polydextrose, Stachyose, Isomaltulose, Crystalline Fructose, Maltitol, Lactitol, Isomalt, and more. To ensure production quality and sustainable capacity, the company operates the most advanced production lines with the highest degree of automation. The production workshops are constructed in accordance with GMP standards, and all processesfrom raw material feeding to product fillingare fully automated, ensuring that both the production process and quality control are well ahead of industry peers. Bailong Chuangyuan has obtained multiple international certifications, including BRCGS, FDA, ISO9001, ISO22000, ISO14001, ISO10012, OHSAS18001, IP (Non-GMO), Halal, SEDEX, Kosher, and Organic certificates. (Bailong Chuangyuan is the first domestic enterprise to obtain organic FOS certification. ) Since its establishment, Bailong Chuangyuan has adhered to the entrepreneurial spirit of pioneering, innovation, and vigorous development. Shandong Bailong Chuangyuan is equipped with a provincial technical center and a provincial technology incubation platform, forming an innovative system that integrates R&D, lab-scale testing, pilot-scale testing, incubation, and industrialization. The technology center is equipped with advanced instruments such as Waters High Performance Liquid Chromatographs and Gas Chromatographs.  

Recently, Shandong-based functional sugar leader Bailong Chuangyuan (605016.SH) released its 2025 annual report, reporting dual growth: total operating income reached ~1.379 billion RMB (+19.75% YoY), and net profit attributable to parent hit ~369 million RMB (+50.06% YoY). The company plans to distribute a cash dividend of 1.65 RMB per 10 shares (before tax), with total dividends accounting for 30.20% of its net profit. On the same day, Bailong Chuangyuan announced a 1.6 billion Thai baht (≈340 million RMB) capital increase for its Thai subsidiary, raising the latter’s registered capital from 600 million to 2.2 billion Thai baht (the company holds a 99.9999995% stake). The move aims to fund the "Thailand Smart Factory Project for New Health Food Ingredients," which is under construction and will ease the company’s production capacity shortage upon completion. Overseas markets are key to Bailong Chuangyuan’s business, contributing 68.67% of its 2025 revenue (923 million RMB) with a 32.28% YoY growth and 47.82% gross profit margin—leading all regions. However, the company noted risks from U.S. tariff plans and global economic uncertainties. Founded in 2005 and listed on the Shanghai Stock Exchange in 2021, Bailong Chuangyuan is a top global functional food ingredient manufacturer with over 200 product specifications, serving clients like Nestlé, Unilever and Wahaha. Its stock price rose 10.02% to 26.58 RMB after the annual report release, with an over 80% cumulative gain since its IPO.   Our Core Business   Prebiotics: FOS, GOS, XOS, IMO Dietary Fiber: Resistant Dextrin, Polydetrose Healthy Sweetners: D- Allulose, Crystalline Fructose, Isomaltulose, Isomalt    

    The 2026 China Feed Industry Exhibition will be held from April 18 to 20 at the Nanchang Greenland International Expo Center. As a leading enterprise in the functional sugar sector, Bailong Chuangyuan will make a major presence at the Food & Pet Pavilion, presenting its full range of pet nutrition solutions. We sincerely invite partners from all sectors to visit and discuss the future of the industry. ? Exhibition Information? Date: April 18–20, 2026? Venue: Nanchang Greenland International Expo Center?️ Booth No.: B3B086 ✨ On-Site Highlights Full display of functional ingredients tailored for pets, such as Resistant dextrin, polydextrose, XOS, FOS, GOS and so on. One-stop solutions for pet gut health, weight management, sugar reduction, and sugar substitution One-on-one consultations with technical experts and customized product development support Industry trend insights and targeted business matching opportunities ? Warm Invitation from Bailong Chuangyuan    From April 18 to 20, Bailong Chuangyuan looks forward to welcoming you at the Nanchang Greenland International Expo Center. We are eager to engage in face-to-face discussions with fellow industry professionals and partners worldwide, explore new pathways integrating functional nutrition with pet health, and jointly seize the vast opportunities in the trillion-yuan pet market. Together, let us create a new chapter of high-quality development in the industry.     See you in Nanchang!

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. - First Quarter 2026 Performance Summary   This English translation is provided for reference only. In case of any discrepancy, the original Chinese version shall prevail.   The Company and its entire Board of Directors warrant that this announcement contains no false records, misleading statements, or material omissions, and accept joint and several liability for the authenticity, accuracy, and completeness of its contents.   The preliminary financial data for the first quarter of 2026 disclosed in this announcement have not been audited by an independent auditing firm. Investors are advised to refer to the Company’s First Quarter 2026 Report for final figures and to be aware of potential investment risks. I. Key Financial Data and Indicators for Q1 2026 (Approximate Figures) Note: Figures for the beginning of the reporting period are the same as those disclosed at the end of the previous year.   The following is a written summary of the key financial data:   Income Statement and Key Ratios (Q1 2026 vs. Q1 2025)   Total operating revenue was approximately 390 million RMB, representing a year-on-year increase of approximately 25%. Operating profit was approximately 140 million RMB, an increase of approximately 47% year-on-year. Total profit was approximately 140 million RMB, up by approximately 48% year-on-year. Net profit attributable to shareholders was approximately 120 million RMB, an increase of approximately 48% compared with the same period last year. Recurring net profit attributable to shareholders was approximately 120 million RMB, up by approximately 46% year-on-year. Basic earnings per share (EPS) was approximately 0.29 RMB, an increase of approximately 16%. Weighted average return on equity (ROE) was approximately 5.8%, representing an increase of 1.1 percentage points year-on-year.   Balance Sheet Data (End of Q1 2026 vs. Beginning of 2026) Total assets were approximately 2.80 billion RMB, an increase of approximately 15% compared with the beginning of the period. Total equity attributable to shareholders was approximately 2.08 billion RMB, up by approximately 6%. Total share capital remained unchanged at approximately 420 million shares. Net assets per share attributable to shareholders was approximately 4.96 RMB, an increase of approximately 6%.   II. Explanation of Operating and Financial Performance (A) Operating Performance In the first quarter of 2026, the Company maintained normal production and operations, with business activities proceeding as usual both domestically and internationally. Revenue grew steadily, and profit increased rapidly.   Total operating revenue for the first quarter of 2026 was approximately 390 million RMB, representing a year-on-year increase of approximately 25%. Net profit attributable to shareholders was approximately 120 million RMB, up by approximately 48% year-on-year. Recurring net profit attributable to shareholders was approximately 120 million RMB, an increase of approximately 46% year-on-year.   The main reasons for the growth are as follows: Increased product sales volume due to rising demand from both domestic and overseas customers; and Strong demand for high-value-added products, supported by an optimized product mix. (B) Financial Position As of the end of the first quarter of 2026, the Company’s financial position remained solid. Total assets stood at approximately 2.80 billion RMB, representing an increase of approximately 15% from the beginning of the period. Total share capital was approximately 420 million shares.   III. Risk Warning The financial data contained in this announcement are preliminary, unaudited estimates. Investors are reminded to refer to the audited figures in the Company’s official First Quarter 2026 Report and to exercise caution regarding investment risks.   IV. Available Documents Comparative balance sheet and income statement signed and sealed by the Company’s principal responsible person, chief accounting officer, and accounting department head.   Note: The Company is primarily engaged in the R&D, production, and sale of prebiotic series, dietary fiber series, healthy sweetener series, and other starch sugar products.  

Allulose is a type of low-calorie sweetener that is becoming increasingly popular in the food and beverage industry. It belongs to a group of rare sugars and has a similar taste and texture to regular sugar, making it a practical alternative in many applications. Shandong Bailong Chuangyuan is the 1st manufacturer in China to produce D-Allulose.  What Is Allulose? Allulose is a naturally occurring sugar found in small quantities in foods such as fruits and grains. For commercial use, it is typically produced from plant-based sources like corn through an enzymatic process. One of its main advantages is that it provides sweetness with significantly fewer calories than traditional sugar. It also has a minimal impact on blood glucose levels, which makes it suitable for products designed for sugar reduction or controlled diets. Unlike some artificial sweeteners, allulose behaves similarly to sugar during food processing. It can provide bulk, texture, and browning, which are important for maintaining product quality. Key Features of Allulose Low calorie compared to regular sugar Mild, clean sweetness similar to sucrose Low glycemic impact Good stability in processing Supports sugar reduction without major formula changes Because of these properties, allulose is widely used as a functional sugar ingredient rather than just a high-intensity sweetener. How Is It Used in Food Products Allulose can be used across a wide range of product categories. It is especially suitable for manufacturers looking to develop low-sugar or reduced-calorie products. 1. Beverages Allulose is commonly used in soft drinks, flavored water, and functional beverages. It provides a natural sweetness without adding significant calories, making it ideal for “low sugar” or “no added sugar” formulations. 2. Baked Goods In bakery products such as bread, cakes, and cookies, allulose helps maintain moisture and texture. It also supports browning during baking, which improves the appearance and flavor of finished products. 3. Dairy Products Allulose is used in yogurt, ice cream, and other dairy items. It contributes to smooth texture and can help control freezing properties in frozen desserts. 4. Confectionery In sugar-free or reduced-sugar candy and gummies, allulose provides bulk and sweetness while supporting a better mouthfeel compared to some alternative sweeteners. 5. Nutritional and Functional Foods Allulose is widely used in protein bars, meal replacements, and dietary supplements. It helps improve taste while keeping overall sugar content low.

D-allulose is becoming the next top alternative sweetener after erythritol. Approved in China in July 2025, it has been widely used in Europe and the US for nearly 10 years and is entering a fast-growth period.   Advantages over erythritol Smooth taste, no cooling sensation (70% sweetness of sucrose) Supports baking browning & caramelization Near-zero calories, no blood sugar rise, better digestionClean-label, natural and healthy   Global applications baking, chocolate, drinks, dairy, sauces, used by Hershey’s, Mars, Coca-Cola, PepsiCo.   China regulation new food raw material; max 20g/day; not for infants, pregnant & lactating women.   Allulose and erythritol are complementary. Allulose for premium baking & high-end food; erythritol for cost-effective drinks & snacks. Blended use is the mainstream trend.   China’s allulose market is expected to boom in 2026–2027.   About Us   Shandong Bailong Chuangyuan，China listed company, 10+ years R&D in D-allulose, leading manufacturer of functional sweeteners.   Annual capacity: 300,000 tons. Certifications: EU/US Organic, HALAL, KOSHER, ISO, NON GMO, BRC.   Supply stable D-allulose, FOS, IMO, XOS, polydextrose, maltitol etc. for sugar-free food & beverages.   Contact us for samples and best quotation!    

  On March 17, the 29th China International Food Ingredients and Additives Exhibition (FIC 2026)—the annual flagship event of the global food ingredients industry—grandly opened at the Shanghai National Exhibition and Convention Center. The Chairman of Bailong Chuangyuan led the company’s senior management team in attendance, arriving in full force for this spring gathering to engage in in-depth exchanges with domestic and international business partners and industry experts, jointly exploring new directions for industrial development in the era of “comprehensive health and nutrition.” As a leading company with deep expertise in the health ingredients sector, Bailong Chuangyuan is showcasing a strong lineup at this exhibition, highlighting its core products and innovative achievements in areas such as prebiotics, dietary fiber, and healthy sweeteners. The Bailong Chuangyuan team gathered at FIC not only to showcase its products but also to send a clear signal of the company’s commitment to its global strategic expansion. Leveraging a dual-drive model of “R&D in China + Smart Manufacturing in Thailand,” the company has established a smart factory in Thailand to capitalize on the region’s cost advantages in raw materials and expand into markets across Southeast Asia, Europe, and the Americas. At the same time, the company continues to increase its R&D investment, focusing on high-end applications such as infant formula and senior health supplements to drive continuous innovation in the functional sugar sector. Leveraging its leading position in the integration of domestic and international trade, Bailong Chuangyuan is bringing high-quality functional sugar products to dining tables around the world. At the exhibition, our team engaged in extensive and in-depth discussions with partners and industry experts from around the world. There was a consensus that, as consumers become increasingly health-conscious, food ingredients are shifting from a “supporting role” to a “functional vehicle,” and that “clean label,” “functionality,” and “sustainability” will become the core keywords in future product development. As a pioneer in China’s functional sugar industry, Bailong Chuangyuan has always regarded technological innovation as its core driving force. Moving forward, the company will continue to leverage its leading position in niche markets such as resistant dextrin and allulose, collaborating with global partners to jointly promote the high-quality development of the food additive and health ingredient industries, and enable this “sweet enterprise” originating from the East to shine even more brilliantly on the world stage. Shandong Bailong Chuangyuan is a national high & new technology enterprise with biological engineering as the leading industry, which integrates production, study and research. It is the backbone enterprises of “Functional sugar city of China” and it has the greatest kinds of functional sugar in China. The domestic earliest enterprise produce Soluble dietary fiber, Resistant dextrin and the sole enterprise which get Production license. We are also the first enterprise to produce Allulose in industrial-scale.